Diana Auyeung-Kim’s Post

View profile for Diana Auyeung-Kim, graphic

Executive Director; Head of gRED Nonclinical Operations (gNO), Safety Assessment at Genentech

Happy to share I’ve been reappointed to California’s Developmental and Reproductive Toxicant Identification Committee again! https://lnkd.in/gK4qx_Q8

Governor Newsom Announces Appointments 5.3.24 | California Governor

Governor Newsom Announces Appointments 5.3.24 | California Governor

gov.ca.gov

Sharon Mullins

Analytical Chemist at FUJIFILM Irvine Scientific

2mo

So excellent. So happy to were reappointed. Keep it up.

Like
Reply
Linval DePass

Consultant in Nonclinical Drug Development

2mo

Congratulations on your appointment!

Like
Reply
Marie C. Fortin, PhD, DABT, ERT, ATS

Therapeutic Area Lead - Immunology @ Merck

1mo

Congratulations! I know you'll make outstanding contributions!

Like
Reply
Terry Martin, DVM, MS, DABVT, DABT

Executive Director, Toxicology at Intra-Cellular Therapies

2mo

Congrats

Like
Reply
Christopher Choi, PhD, DABT, ERT

Vice President, Safety and Regulatory at Takasago International Corporation

2mo

That’s pretty cool!

Like
Reply
Maryam Tarazkar

principal AI Scientist at Genentech

2mo

Big congratulations! Well deserved

Like
Reply
James Scull, PhD

President at PHARMXTRAX

2mo

WOW!! THAT'S AWESOME!

Like
Reply
LeAnn Fong-Batkin

Passionate about data systems, equity for all students, intersegmental collaborations, and policy

2mo

Awesome!! Congratulations!!

Like
Reply
Mayssa Attar

Innovator I Biopharmaceutical Scientist I Talent Magnet

2mo

Thats awesome Diana - you will be great!

Like
Reply
Justine Cunningham PhD, DABT

VP, Nonclinical Development, RegenX Bio

2mo

Congratulations Diana

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics